Variables | ABO-compatible (n = 53) | ABO-identical (n = 262) | p-value |
---|---|---|---|
Recipient data | |||
Recipients major indication | 0.240 | ||
COPD | 10 (18.9%) | 64 (24.4%) | |
AAT1 | 9 (17.0%) | 49 (18.7%) | |
PH | 7 (13.2%) | 29 (11.1%) | |
CF | 15 (28.3%) | 43 (16.4%) | |
PF | 9 (17.0%) | 35 (13.4%) | |
Others | 2 (3.8%) | 25 (9.5%) | |
Graft failure (Re-LTx) | 1 (1.8%) | 17 (6.5%) | |
CMV serology (pos) | 39 (73.6%) | 205 (78.2%) | 0. 573 |
EBV serology (pos) | 37 (69.8%) | 184 (70.2%) | 0. 920 |
Toxoplasma serology (pos) | 14 (26.4%) | 62 (23.7%) | 0. 680 |
CMV-mismatch | 8 (15.1%) | 41 (15.6%) | 0. 911 |
EBV-mismatch | 5 (9.4%) | 17 (6.5%) | 0. 448 |
Toxoplasma mismatch | 6 (11.3%) | 31 (11.8%) | 0. 916 |
Weight (kg) | 64. 3 ± 19. 9 | 59. 8 ± 12. 5 | 0. 032 |
Recipient/Donor weight ratio | 0. 9 (0. 4–3. 1) | 0. 8 (0. 4–1. 6) | 0. 034 |
Height (cm) | 169. 1 ± 9. 1 | 168. 6 ± 10. 4 | 0. 703 |
Recipient/Donor height ratio | 1. 0 (0. 9–2. 4) | 0. 9 (0. 8–1. 1) | 0. 692 |
BMI | 22. 2 ± 4. 2 | 20. 9 ± 3. 7 | 0. 045 |
Male | 28 (52.8%) | 124 (47.3%) | 0. 465 |
Gender mismatch | 16 (30.2%) | 90 (34.4%) | 0. 523 |
Age (years) | 45. 5 (12. 2–70. 6) | 52. 9 (12. 4–72. 0) | 0. 159 |
Recipient/Donor age ratio | 0. 97 (0. 30–3. 92) | 1. 03 (0. 27–3. 99) | 0. 102 |
Waiting list (days) | 49.0 (2. 0–641. 0) | 89. 0 (1. 0–1717. 0) | 0. 048 |
Lab values | |||
FVC (liters) | 2. 0 (0. 7–5. 2) | 2. 1 (0. 3–5. 3) | 0. 233 |
FEV1 (liters) | 0. 9 (0. 2–2. 6) | 0. 8 (0. 2–3. 4) | 0. 735 |
6MWT (%) | 39. 4 ± 20. 3 | 38. 6 ± 19. 4 | 0. 813 |
P-ALT (μkat/L) | 0. 4 (0. 1–9. 7) | 0. 4 (0. 1–1. 6) | 0. 128 |
P-AST (μkat/L) | 0.5 (0. 2–10. 0) | 0. 4 (0. 2–2. 3) | 0. 340 |
P-creatinine (μmol/L) | 66 (22–234) | 62 (26–217) | 0. 255 |
Pulm. pressure > 25mmhg | 20 (37.8%) | 70 (26.7%) | 0. 110 |
Tx-type | 0. 121 | ||
SLTx | 14 (26.5%) | 86 (32.8%) | |
DLTx | 36 (67.9%) | 157 (59.9%) | |
HLTx | 2 (3.8%) | 2 (0.8%) | |
Re-LTx | 1 (1.8%) | 17 (6.5%) | |
SLTx | 1 (100%) | 9 (52.9%) | |
DLTx | 0 (0%) | 8 (47.1%) | |
ATG | 35 (66.0%) | 172 (65.6%) | 0. 908 |
Pre-op Life support | |||
Mechanical ventilation | 2 (3.8%) | 12 (4.6%) | 0. 795 |
ECMO | 3 (5.7%) | 9 (3.4%) | 0. 673 |
Donor data | |||
CMV serology (pos) | 32 (60.4%) | 172 (65.6%) | 0. 547 |
EBV serology (pos) | 22 (41.5%) | 139 (53.1%) | 0. 119 |
Toxoplasma serology (pos) | 8 (15.1%) | 48 (18.3%) | 0. 568 |
Weight (kg) | 70 (19–180) | 71 (40–105) | 0. 901 |
Height (cm) | 170 (70–198) | 170 (150–190) | 0. 886 |
BMI | 23. 9 (6. 2–34. 6) | 23. 9 (14. 7–35. 9) | 0. 999 |
Male | 27 (50.9%) | 119 (45.4%) | 0. 506 |
Age (years) | 50. 5 (12. 2–71. 4) | 47. 0 (7. 8–75. 4) | 0. 463 |